IP Library Granted Patent US 9,186,198
Granted Patent B2
US 9,186,198 · App. 13/620,043 · Granted Nov 17, 2015

Ultrasound apparatuses for thermally-induced renal neuromodulation and associated systems and methods

Inventors: Denise Demarais (Saratoga, CA); Nicolas Zadno (Fremont, CA); Benjamin J. Clark (Redwood City, CA); Erik Thai (San Jose, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/12A61B18/02A61B18/04A61B18/1492A61F7/007A61F7/12A61F7/123A61M5/44A61N1/28A61N1/403A61N5/045A61N7/00A61N7/02A61B2018/0022A61B2018/00434A61B2018/00511A61B2018/00577A61F2007/126A61M2210/1082A61N1/36007A61N2007/003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,186,198
App. No.
13/620,043
Granted
Nov 17, 2015
Kind
B2
Abstract

Methods and apparatus are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues.

Claims (14)

1. A method for catheter-based renal neuromodulation, the method comprising:

positioning a catheter having a therapeutic element within a renal blood vessel of a human patient and proximate to neural fibers associated with renal function, wherein the therapeutic element comprises one or more ultrasound transducers positioned along the catheter; and

thermally inhibiting neural activity along the neural fibers via ultrasound energy from the therapeutic element.

2. The method of claim 1 , wherein positioning the catheter having the therapeutic element within the renal blood vessel comprises intravascularly positioning the catheter having the one or more ultrasound transducers within a renal artery of the patient.

3. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers comprises delivering ultrasound energy via the one or more ultrasound transducers to a renal nerve proximate to a renal artery of the patient.

4. The method of claim 3 , wherein transferring ultrasound energy via the one or more ultrasound transducers to the renal nerve of the patient comprises transmitting the ultrasound waves over a full 360° about the catheter.

5. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers comprises blocking neural traffic to and/or from a kidney of the patient.

6. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers comprises ablating a renal nerve of the patient via ultrasound energy from the one or more ultrasound transducers.

7. The method of claim 1 , wherein the catheter comprises an inflatable balloon proximate to the one or more ultrasound transducers, and wherein positioning the catheter having the therapeutic element within the renal blood vessel comprises intravascularly delivering the inflatable balloon to the renal blood vessel in a reduced delivery and retrieval configuration and expanding the balloon to a deployed configuration within the renal blood vessel.

8. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers comprises ablating the neural fibers.

9. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers alleviates clinical symptoms of hypertension in the patient.

10. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers alleviates clinical symptoms of atrial fibrillation in the patient.

11. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers alleviates clinical symptoms of renal disease in the patient.

12. The method of claim 1 , wherein thermally inhibiting neural activity along the neural fibers alleviates clinical symptoms of Congestive Heart Failure in the patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 030531/0717 →
CHANGE OF NAME Recorded Jun 3, 2013
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 030531/0816 →
Continuity (13)
Continuation 12754337 · Apr 5, 2010
Continuation 11840142 · Aug 16, 2007
Continuation 11504117 · Aug 14, 2006
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Provisional Application 60816999 · Jun 28, 2006
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Related Publication 20130012844A1 · Jan 10, 2013